Neonatal Hyperbilirubinemia Admissions Following Clinical Practice Guideline Implementation
Military Medicine · 18.05.2024 · 189 (5-6) · e1259-e1262
DOI: 10.1093/milmed/usad427 ↗Kurz gefasst
Leitlinie in der Zeitschrift Military Medicine, online erschienen am 07.11.2023. Verfasst von Morgan Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Residency Program, Tripler Army Medical Center, Honolulu, HI 96859, USA. Hauptthemen laut MEDLINE: Hyperbilirubinemia, Neonatal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Introduction
Treatment of neonatal hyperbilirubinemia remains one of the most common reasons for readmission following delivery. Revised clinical practice guidelines (CPGs) for the treatment of neonatal hyperbilirubinemia were published on August 5, 2022. This report describes the preliminary outcomes following implementation of the new CPGs at Tripler Army Medical Center. Materials and Methods A retrospective chart review was performed for the 12 months prior to implementation and the 5 months post implementation.
Results
Bilirubin admissions decreased from 15.6% of total admissions during the 12 months prior to the new guidelines (69/441) to 4.1% of admissions (8/194) during the 5 months after implementation of the new guidelines (P < 0.001). This corresponds to a 74% reduction (risk ratio = 0.26, 95% confidence interval [CI] 0.13 to 0.54). The decrease in admissions was found to correlate to greater than $140,000 in annual savings.
Conclusion
Adhering to the revised CPGs has the potential to increase resource availability at a time when nursing shortages and financial instability are impacting health care systems nationwide. No short-term adverse events were noted; however, long-term follow up will be needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pediatric Residency Program, Tripler Army Medical Center, Honolulu, HI 96859, USA.
- Pediatric Faculty, The University of Uniformed Services, Bethesda, MD 20814, USA.
ORCID-Profile: Morgan Smith, Dolores Mullikin
Zitieren
APA
Smith, M., Ridgway, A., & Mullikin, D. (2024). Neonatal Hyperbilirubinemia Admissions Following Clinical Practice Guideline Implementation. Military Medicine, 189(5-6), e1259-e1262. https://doi.org/10.1093/milmed/usad427
Vancouver
Smith M, Ridgway A, Mullikin D. Neonatal Hyperbilirubinemia Admissions Following Clinical Practice Guideline Implementation. Military Medicine. 2024;189(5-6):e1259-e1262. doi:10.1093/milmed/usad427
BibTeX
@article{Smith2024,
author = {Smith, Morgan and Ridgway, Austin and Mullikin, Dolores},
title = {Neonatal Hyperbilirubinemia Admissions Following Clinical Practice Guideline Implementation},
journal = {Military Medicine},
year = {2024},
volume = {189},
number = {5-6},
pages = {e1259--e1262},
doi = {10.1093/milmed/usad427}
}
EUVIMED